BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30195484)

  • 21. Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS.
    Bowers J; Hughes E; Skill N; Maluccio M; Raftery D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():154-62. PubMed ID: 24666728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey.
    Toyoda H; Tada T; Johnson PJ; Izumi N; Kadoya M; Kaneko S; Kokudo N; Ku Y; Kubo S; Kumada T; Matsuyama Y; Nakashima O; Sakamoto M; Takayama T; Kudo M;
    J Gastroenterol; 2017 Oct; 52(10):1112-1121. PubMed ID: 28224228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal staging system for predicting the prognosis of patients with hepatocellular carcinoma in China: a retrospective study.
    Su L; Zhou T; Zhang Z; Zhang X; Zhi X; Li C; Wang Q; Jia C; Shi W; Yue Y; Gao Y; Cheng B
    BMC Cancer; 2016 Jul; 16():424. PubMed ID: 27387757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue and serum metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.
    Han J; Qin WX; Li ZL; Xu AJ; Xing H; Wu H; Zhang H; Wang MD; Li C; Liang L; Quan B; Yan WT; Shen F; Wu MC; Yang T
    Clin Chim Acta; 2019 Jan; 488():68-75. PubMed ID: 30389456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.
    Zhang H; Yao M; Wu W; Qiu L; Sai W; Yang J; Zheng W; Huang J; Yao D
    Tumour Biol; 2015 Dec; 36(12):9373-83. PubMed ID: 26109000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.
    Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L
    Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma.
    Grammatikos G; Schoell N; Ferreirós N; Bon D; Herrmann E; Farnik H; Köberle V; Piiper A; Zeuzem S; Kronenberger B; Waidmann O; Pfeilschifter J
    Oncotarget; 2016 Apr; 7(14):18095-105. PubMed ID: 26933996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients.
    Carr BI; Guerra V
    Int J Biol Markers; 2017 Oct; 32(4):e391-e396. PubMed ID: 28862714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylcarnitine Is a Candidate Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma.
    Lu Y; Li N; Gao L; Xu YJ; Huang C; Yu K; Ling Q; Cheng Q; Chen S; Zhu M; Fang J; Chen M; Ong CN
    Cancer Res; 2016 May; 76(10):2912-20. PubMed ID: 26976432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.
    El-Abd N; Fawzy A; Elbaz T; Hamdy S
    Tumour Biol; 2016 Jan; 37(1):211-6. PubMed ID: 26189841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.
    Chan SL; Mo F; Johnson P; Li L; Tang N; Loong H; Chan AW; Koh J; Chan AT; Yeo W
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1529-35. PubMed ID: 25968302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
    Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
    Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y
    Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic and Prognostic Value of Talin-1 and Midkine as Tumor Markers in Hepatocellular Carcinoma in Egyptian Patients.
    Mashaly AH; Anwar R; Ebrahim MA; Eissa LA; El Shishtawy MM
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1503-1508. PubMed ID: 29936723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
    Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
    J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography-mass spectrometry.
    Passos-Castilho AM; Carvalho VM; Cardozo KH; Kikuchi L; Chagas AL; Gomes-Gouvêa MS; Malta F; de Seixas-Santos Nastri AC; Pinho JR; Carrilho FJ; Granato CF
    BMC Cancer; 2015 Dec; 15():985. PubMed ID: 26680993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients.
    Yen YH; Changchien CS; Wang JH; Kee KM; Hung CH; Hu TH; Lee CM; Lin CY; Wang CC; Chen TY; Huang YJ; Lu SN
    Dig Liver Dis; 2009 Jun; 41(6):431-41. PubMed ID: 19185555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and prognostic significance of secretory clusterin expression in patients with hepatocellular carcinoma.
    Zheng W; Yao M; Sai W; Qian Q; Pan L; Qiu L; Huang J; Wu W; Yao D
    Tumour Biol; 2016 Jan; 37(1):999-1008. PubMed ID: 26264614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.